Sickle Cell Disease News and Research

Latest Sickle Cell Disease News and Research

Tranylcypromine may also hold promise in treating sickle cell disease

Tranylcypromine may also hold promise in treating sickle cell disease

Gamida Cell announces results from NiCord Phase I/II study on hematological malignancies

Gamida Cell announces results from NiCord Phase I/II study on hematological malignancies

Dilaforette receives approval to initiate sevuparin Phase II malaria study in India

Dilaforette receives approval to initiate sevuparin Phase II malaria study in India

TAPS supports preoperative transfusion

TAPS supports preoperative transfusion

Clinical trial to evaluate cyclodextrin against Niemann-Pick disease type C1

Clinical trial to evaluate cyclodextrin against Niemann-Pick disease type C1

Penn Medicine to establish new center for treatment and research of blood diseases

Penn Medicine to establish new center for treatment and research of blood diseases

Enrollment complete in GlycoMimetics’ GMI-1070 Phase 2 study for sickle cell disease

Enrollment complete in GlycoMimetics’ GMI-1070 Phase 2 study for sickle cell disease

Research unveils key gaps in continuity of care for sickle cell patients

Research unveils key gaps in continuity of care for sickle cell patients

Acetylon announces results from selective HDAC 1/2 inhibitor preclinical study on SCD and bT

Acetylon announces results from selective HDAC 1/2 inhibitor preclinical study on SCD and bT

Patients with sickle cell disease rely more on emergency room

Patients with sickle cell disease rely more on emergency room

Sickle cell disease trial completes phase 3 patient enrollment

Sickle cell disease trial completes phase 3 patient enrollment

ADVENTRX Pharmaceuticals updates corporate website

ADVENTRX Pharmaceuticals updates corporate website

CINJ experts available to comment on importance and uses of blood donations

CINJ experts available to comment on importance and uses of blood donations

Acetylon's ective histone deacetylase inhibitors to be showcased at 54th ASH annual meeting

Acetylon's ective histone deacetylase inhibitors to be showcased at 54th ASH annual meeting

Sickle cell disease treatments: An interview with Dr Niihara, CEO of Emmaus Medical

Sickle cell disease treatments: An interview with Dr Niihara, CEO of Emmaus Medical

Researchers identify painful symptoms of sickle cell disease

Researchers identify painful symptoms of sickle cell disease

Study demonstrates efficacy of genotyping technology in identifying source of clinic infection outbreak

Study demonstrates efficacy of genotyping technology in identifying source of clinic infection outbreak

Haploidentical bone marrow transplants for sickle cell disease: an interview with Dr. Javier Bolaños Meade

Haploidentical bone marrow transplants for sickle cell disease: an interview with Dr. Javier Bolaños Meade

Wheeze predicts sickle cell disease crisis

Wheeze predicts sickle cell disease crisis

New clinical trial to evaluate DEX-M74 against hereditary inclusion body myopathy

New clinical trial to evaluate DEX-M74 against hereditary inclusion body myopathy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.